Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study
R. Andrew P. Skyrme-Jones, BSc, MB, ChB*,1,
Richard C. OBrien, MBBS, PhD ,
Karen L. Berry, BSc* and
Ian T. Meredith, MBBS, PhD*
* Centre for Heart and Chest Research, Monash Medical Centre and Monash University, Melbourne, Australia
Department of Medicine, Monash Medical Centre and Monash University, Melbourne, Australia

View larger version (22K):
[in a new window]
|
Figure 1 a, Plasma VEC in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin Etreated subgroup (open bar at baseline; solid bar after treatment). b, Low density lipoprotein VEC in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin Etreated subgroup (open bar at baseline; solid bar after treatment).
|
|

View larger version (25K):
[in a new window]
|
Figure 2 a, Flow-mediated dilation in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin Etreated subgroup (open bar at baseline; solid bar after treatment). Flow-mediated dilation was not altered in the placebo group, but showed a significant increase after vitamin E therapy. b, Nitroglycerin-induced vasodilation. After vitamin E supplementation, there was a trend toward an improvement in the NTG response.
|
|

View larger version (17K):
[in a new window]
|
Figure 4 Absolute forearm blood flow (a) and absolute forearm vascular resistance (b) during graded intra-arterial infusion of ACh before (open circles) and after (solid circles) therapy with vitamin E and before (open squares) and after (solid squares) placebo. Absolute forearm blood flow and vascular resistance were augmented after vitamin E therapy, but there was no change in the response in the placebo group (ANOVA, p < 0.05).
|
|
|